Potential patient benefit of a subcutaneous formulation of tocilizumab for the treatment of rheumatoid arthritis: a critical reviewReview Published on 2014-08-012024-09-04 Journal: Molecular pharmacology [Category] 대상포진, [키워드] Efficacy pharmacokinetic rheumatoid arthritis Safety Subcutaneous Tocilizumab [DOI] 10.2147/PPA.S34958 PMC 바로가기 [Article Type] Review